Saurabh Sewak

Saurabh Sewak, PhD, is a seasoned professional in the biopharma industry with extensive experience in business development, corporate strategy, and commercial operations. Currently serving as the Head of Business Development and Vice President of Corporate Development at Foghorn Therapeutics Inc., Saurabh leads initiatives for clinical and preclinical oncology assets and oversees corporate strategy across transcription factor inhibition and targeted protein degradation. Additionally, Saurabh holds the role of Vice Chair on the Board of Trustees for the Leukemia & Lymphoma Society to enhance representation for minority and historically underrepresented patients. As the founder of Sewaa Strategies Biopharma Advisory, Saurabh provides strategic guidance to biotech firms on corporate strategy and clinical development. Previous roles include leadership positions at Ipsen, TESARO, and Biogen, where Saurabh successfully built teams, shaped disease strategies, and drove organizational transformations. Saurabh holds a PhD and an MS in Pharmacy from the University of Mississippi, along with a Bachelor of Pharmacy degree from Savitribai Phule Pune University.